No profile data available.
Profound Medical Corp. (PROF) is a healthcare company in the various healthcare equipment manufacturing industry, based in Mississauga, Canada, with about 142 full-time employees.
It reported revenue of $10.68 million for fiscal year 2024, up 48.4% from fiscal year 2023, and net income of -$27.82 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $5.29 million, up 86.8% from a year before. United States of America was its largest region in fiscal year 2025, with 76% of revenue. Its market capitalization was $207.09 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
, together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.
Profound Medical reported $10.68 million in revenue for fiscal year 2024, up 48.4% from $7.20 million in fiscal year 2023. In Q3 2025 revenue was $5.29 million.
United States of America: 76% of revenue by region in fiscal year 2025, followed by Canada (19%).
$207.09 million as of December 4, 2025.
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Artivion, Inc. (AORT), MiMedx Group, Inc. (MDXG), AngioDynamics, Inc. (ANGO), Harvard Bioscience, Inc. (HBIO).